Corium International Inc (CORI)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

235 CONSTITUTION DRIVE MENLO PARK, CA 94025

Corium International, Inc develops and manufactures drug delivery products. The company offers polymer and mechanical microporation technologies that allow the development of various delivery systems that deliver drugs across the skin and mucosa.

Data as of 2018-11-27 06:02:28 -0500
Market Cap463.046 Million Shares Outstanding36.518 Million Avg 30-day Volume
P/E Ratio Dividend Yield0.0 EPS-1.57
Price/Sales17.54796 Debt to Equity EBITDA-10.765 Million
Price to Book Value18.56 Forward PE Enterprise Value
Total Cash45.23 Million Current Debt Gross Profit2.426 Million
BETA0.86729 52-week High/Low13.93 / 7.17 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from CORI instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CORI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CORI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BREUIL ROBERT S CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2018-11-27 0

CHAUDHURI BHASKAR

  • Director
No longer subject to file 2018-11-27 0

EASTMAN RONALD W

  • Director
  • 10% Owner
No longer subject to file 2018-11-27 0

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

  • 10% Owner
No longer subject to file 2018-11-27 0

GARDNER PHYLLIS

  • Director
No longer subject to file 2018-11-27 0

GREENWOOD DAVID

  • Director
No longer subject to file 2018-11-27 0

SINGH PARMINDER CTO & VICE PRESIDENT, R&D

  • Officer
No longer subject to file 2018-11-27 0

STAPLE PETER D PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2018-11-27 0

SWEEMER TIMOTHY D CHIEF ACCOUNTING OFFICER

  • Officer
No longer subject to file 2018-11-27 0

THOMAS ROBERT

  • Director
No longer subject to file 2018-11-27 0

GODDARD PAUL

  • Director
No longer subject to file 2018-11-27 0

GERGEL IVAN P.

  • Director
No longer subject to file 2018-11-27 0

BJERKHOLT ERIC

  • Director
No longer subject to file 2018-11-27 0

SARRET JOSEPH J. CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2018-11-27 0

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • 10% Owner
No longer subject to file 2018-11-27 0

GURNET HOLDING CO

GURNET MERGER SUB, INC.

GURNET POINT, L.P.

WAYPOINT INTERNATIONAL GP LLC

  • 10% Owner
31,578,142 2018-11-27 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
No longer subject to file 2018-10-11 0

GURNET HOLDING CO

GURNET MERGER SUB, INC.

GURNET POINT, L.P.

  • 10% Owner
0 2018-10-11 0

KOZARICH JOHN W

  • Director
0 2014-12-04 0

CLEARY GARY W

GARY W. CLEARY & NOBUKO SAITO CLEARY, TRUSTEES OF THE CLEARY-SAITO FAMILY TRUST U/D/T DATED SEPTEMBER 4, 1996

  • Director
  • 10% Owner
290,402 2014-04-08 0

FAASSE ADRIAN

  • 10% Owner
871,207 2014-04-02 0

WELCH DANIEL G

  • Director
0 2014-04-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments